MannKind Corporation (NASDAQ: MNKD) is a biotechnology and pharmaceutical company specializing in inhaled therapeutics for diabetes and pulmonary diseases. Best known for Afrezza®, an inhaled
At the last check today, MannKind Corporation (MNKD) had reached $4.48, good for an increase of 9.27% in premarket session. The MannKind stock price dropped
Fuel Tech Inc. (FTEK) stock plunged -8.8% to $1.14 in the pre-market trading after the technology company offered advanced engineering solutions for the optimization of
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.